Medexus Pharmaceuticals Inc. (MDP:TSX) closed at $4.89 on October 23, 2026, down 1.01% on the day. The stock trades 11.1% below its 52-week high of $5.50 and 94.8% above its 52-week low of $2.51. Over the past year, it gained 73.3%. Medexus Pharmaceuticals Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, MDP closed higher on 121 days (48%). Its best day was June 30, 2026 (+13.59%) and its worst was December 8, 2025 (-4.78%). The stock moved 10% or more in a single session 1 time.
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
Find more stocks like MDP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.